12:00 AM
May 28, 2012
 |  BC Week In Review  |  Company News  |  Deals

Immune Pharmaceuticals, Weizmann Institute of Science deal

Immune partnered with Yeda Research and Development Company Ltd., the institute's technology transfer arm, to develop antibodies against epidermal growth factor receptor 3 (

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >